Sarcoma - PDF Document

Presentation Transcript

  1. Stanford Cancer Institute Sarcoma Version Date: 13 Sept 2019 Soft Tissue Sarcoma Non GIST GIST (Gastrointestinal Stromal Tumors) Perivascular Epithelioid Cell Tumors (PEComa) Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma SARCOMA0024 Pilot Incisional Negative Pressure Wound Tx in Irradiated Lower Extremity Soft Tissue Sarcoma Wounds 2nd-3rd Line Therapy PVNS Desmoid SARCOMA0037 Phase I DCC-3014 in Advanced Tumors SARCOMA0036 Phase III DCC-2618 vs Sunitinib in Advanced Gastrointestinal Stromal Tumors after Tx w/ Imatinib SARCOMA0034 Phase III Nirogacestat vs Placebo in Adult Progressing Desmoid Tumors/Aggressive Fibromatosis(DT/AF) SARCOMA0026 Phase III AL3818 (Anlotinib) MonoTx in Metastatic/Advanced Sarcoma /Leiomyosarcoma /Synovial Sarcoma SARCOMA0028 Phase I DCC-2618 in Advanced Malignancies SARCOMA0039 Expanded Access ABI-009 in Advanced PEComa & Malignancy w/ GeneticMutations /mTOR Pathway Activation PI: Avedian Medical University South Carolina PI: Ganjoo Pending PI: Ganjoo Deciphera Pharmaceuticals PI: Kummar SprimgWorks Therapeutics PI: Ganjoo Deciphera Pharmaceuticals PI: Kummar Advenchen Laboratories PI: Ganjoo Pending KEY Pending Optional Path Extension Study ? Open for Enrollment Link Trial PostingImmunotherapy Observational Study Enrollment on Hold Please mark up a copy using black ink and email changes to SRC-office@stanford.edu